MOH Investors Have Opportunity to Lead Molina Healthcare, Inc. Securities Fraud Lawsuit with the Schall Law Firm

15.10.25 09:01 Uhr

Werte in diesem Artikel
Aktien

164,15 EUR -2,75 EUR -1,65%

LOS ANGELES, Oct. 15, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Molina Healthcare, Inc. ("Molina" or "the Company") (NYSE: MOH) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

(PRNewsfoto/The Schall Law Firm)

Investors who purchased the Company's securities between February 5, 2025 and July 23, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before December 2, 2025.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at bschall@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Molina withheld adverse information about its "medical cost trend assumptions." The Company suffered from a "dislocation between premium rates and medical cost trend." The Company was likely to cut its financial guidance for fiscal year 2025. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about Molina, investors suffered damages.

Join the case to recover your losses

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.          

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
info@schallfirm.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/moh-investors-have-opportunity-to-lead-molina-healthcare-inc-securities-fraud-lawsuit-with-the-schall-law-firm-302584371.html

SOURCE The Schall Law Firm

In eigener Sache

Übrigens: Molina Healthcare und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf Molina Healthcare

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Molina Healthcare

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Nachrichten zu Molina Healthcare

Wer­bung

Analysen zu Molina Healthcare

DatumRatingAnalyst
03.06.2019Molina Healthcare OutperformBMO Capital Markets
20.10.2017Molina Healthcare Market PerformBMO Capital Markets
31.05.2017Molina Healthcare SellStifel, Nicolaus & Co., Inc.
05.04.2017Molina Healthcare HoldDeutsche Bank AG
21.03.2017Molina Healthcare Equal WeightBarclays Capital
DatumRatingAnalyst
03.06.2019Molina Healthcare OutperformBMO Capital Markets
20.10.2017Molina Healthcare Market PerformBMO Capital Markets
16.02.2017Molina Healthcare HoldStifel, Nicolaus & Co., Inc.
29.04.2016Molina Healthcare BuyStifel, Nicolaus & Co., Inc.
31.07.2015Molina Healthcare BuyStifel, Nicolaus & Co., Inc.
DatumRatingAnalyst
05.04.2017Molina Healthcare HoldDeutsche Bank AG
21.03.2017Molina Healthcare Equal WeightBarclays Capital
02.11.2015Molina Healthcare Equal WeightBarclays Capital
02.06.2015Molina Healthcare HoldDeutsche Bank AG
13.02.2015Molina Healthcare Equal WeightBarclays Capital
DatumRatingAnalyst
31.05.2017Molina Healthcare SellStifel, Nicolaus & Co., Inc.

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Molina Healthcare nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen